TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29405780

Group type: EXPERIMENTAL
Intervention: High-protein diet (HP: 2.5 g·kg‐1·day‐1; n=8)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-protein diet (LP: 0.9 g·kg‐1·day‐1; n=9)
Number of subjects: 17
Study: 26879181

Group type: EXPERIMENTAL
Intervention: Individualised acupuncture (IA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 164
Study: 24112515

Group type: EXPERIMENTAL
Intervention: Nevirapine XR formulation
Number of subjects: 800
Study: 23148455

Group type: EXPERIMENTAL
Intervention: Negative mood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive mood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High plausibility messages under sad mood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fidgety nonverbal cues under happy mood
Number of subjects: 0
Study: 20467878

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 50 microg fentanyl (group BF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 4 mg dexamethasone (group BD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epidural plain bupivacaine 0.25% (control group B)
Number of subjects: 90
Study: 17052369

Group type: EXPERIMENTAL
Intervention: Re‐operative thyroid surgery (group one)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (group two)
Number of subjects: 125
Study: 16034009

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study: 11570653

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Peer discussion intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Education plus peer discussion intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study: 9646062

Group type: EXPERIMENTAL
Intervention: Amorphous erythromycin ethylsuccinate (500 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Crystalline erythromycin ethylsuccinate (1000 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7884020

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Cocaine (20 mg and 40 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Fluoxetine and cocaine
Number of subjects: 5
Study: 3220956

Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 12.5 mg meclizine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: both methylphenidate and meclizine
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 1678703

Group type: EXPERIMENTAL
Intervention: NEMG (neck electromyography) recordings
Number of subjects: 10

Group type: COMPARATOR
Intervention: FEMG (frontal electromyography) recordings
Number of subjects: 10
Study: 73796

Group type: EXPERIMENTAL
Intervention: Addition of 16 g guar and 10 g pectin to the control meal
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control meal containing 106 g carbohydrate
Number of subjects: 11
Study: 31800368

Group type: EXPERIMENTAL
Intervention: Video counseling series provided through Zoom
Number of subjects: 0
Study: 30729735

Group type: EXPERIMENTAL
Intervention: 4S soothing techniques (swaddling, holding at side or stomach position, shushing‐white noise, swinging)
Number of subjects: 42
Study: 29236097

Group type: EXPERIMENTAL
Intervention: I-PASS
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Policy mandate on task accountability
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Plan-Do-Study-Act (PDSA)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Didactics
Number of subjects: 4
Study: 25884899

Group type: EXPERIMENTAL
Intervention: target‐lesion SYNTAX score (tSS)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: tSS
Number of subjects: 420
Study: 23601001

Group type: EXPERIMENTAL
Intervention: Irrigated radiofrequency current (RFC)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cryoballoon (CB)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Laser balloon (LB)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study: 21741700

Group type: EXPERIMENTAL
Intervention: Formal one-to-one pelvic floor muscle training (4 sessions over 3 months)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Standard care and lifestyle advice only (Control)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Both trials (combined)
Number of subjects: 390
Study: 19627897

Group type: EXPERIMENTAL
Intervention: Laterally wedged insole alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Concurrent use of ankle support with wedged insole
Number of subjects: 14
Study: 17119140

Group type: EXPERIMENTAL
Intervention: Standard open diskectomy
Number of subjects: 501

Group type: COMPARATOR
Intervention: Nonoperative treatment individualized to the patient
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Both treatment groups (surgery and nonoperative)
Number of subjects: 501
Study: 15149345

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: High baseline albuminuria (> or =3.0 g/g creatinine)
Number of subjects: 1513
Study: 11553243

Group type: EXPERIMENTAL
Intervention: Right lateral position
Number of subjects: 34

Group type: COMPARATOR
Intervention: Left lateral position
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 9559471

Group type: EXPERIMENTAL
Intervention: AcrySof IOL
Number of subjects: 90

Group type: COMPARATOR
Intervention: PMMA IOL
Number of subjects: 90

Group type: COMPARATOR
Intervention: Silicone IOL
Number of subjects: 90
Study: 7878556

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support 18 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pressure support 18 cm H2O + positive end expiratory pressure (PEEP) 6 cm H2O (IPAP+EPAP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) 8 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Volume cycled NIPPV
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 3064454

Group type: EXPERIMENTAL
Intervention: Punctate transcutaneous electric nerve stimulation (PuTENS)
Number of subjects: 740

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 740

Group type: COMPARATOR
Intervention: Medicamentously controlled studies
Number of subjects: 740
Study: 28930284

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 28064349

Group type: EXPERIMENTAL
Intervention: Salivary exposure for 30 min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salivary exposure for 1 h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salivary exposure for 2 h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salivary exposure for 12 h
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no salivary exposure)
Number of subjects: 20
Study: 25361537

Group type: EXPERIMENTAL
Intervention: Individualised psycho-education and 24-month preventive monitoring
Number of subjects: 238

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 238
Study: 23474436

Group type: EXPERIMENTAL
Intervention: Finasteride (5mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 53
Study: 21457567

Group type: EXPERIMENTAL
Intervention: Peer coaching (n = 200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care (n = 200)
Number of subjects: 400
Study: 19041437

Group type: EXPERIMENTAL
Intervention: Levonorgestrel‐releasing intrauterine system (LNG‐IUS)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ortho Gynae T380 intrauterine copper device (IUD)
Number of subjects: 92
Study: 16412866

Group type: EXPERIMENTAL
Intervention: Aspirin 30, 100, or 325 mg/day
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Improved metabolic control
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control patients (healthy volunteers)
Number of subjects: 114
Study: 15622577

Group type: EXPERIMENTAL
Intervention: Artificial bowel sphincter (Acticon Neosphincter)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Supportive care (Control)
Number of subjects: 14
Study: 11484571

Group type: EXPERIMENTAL
Intervention: Aluminous oxide pink stone surface treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 50‐micron aluminum oxide sandblasting surface treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Brown rubber point surface treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gray silicone wheel followed by pink silicone wheel surface treatment
Number of subjects: 20
Study: 9783532

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 20
Study: 10161100

Group type: EXPERIMENTAL
Intervention: 10% dietary fat intake
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 20% dietary fat intake
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 30% dietary fat intake
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 40% dietary fat intake
Number of subjects: 35
Study: 2849376

Group type: COMPARATOR
Intervention: Intranasally administered rhinovirus receptor murine monoclonal antibody (RRMA) 135 micrograms/subject in 9 applications, -17 to +48 h
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intranasally administered rhinovirus receptor murine monoclonal antibody (RRMA) 1 mg/subject in 10 applications, -3 to +36 h
Number of subjects: 28
Study: 30917201

Group type: EXPERIMENTAL
Intervention: SystemCHANGE™ intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 0
Study: 27655918

Group type: EXPERIMENTAL
Intervention: Immediate multivessel PCI
Number of subjects: 600

Group type: COMPARATOR
Intervention: Culprit lesion PCI
Number of subjects: 600
Study: 25411362

Group type: EXPERIMENTAL
Intervention: Postexercise protein-carbohydrate supplementation
Number of subjects: 17

Group type: COMPARATOR
Intervention: No supplementation (control)
Number of subjects: 17
Study: 23537225

Group type: EXPERIMENTAL
Intervention: Grain bar preload
Number of subjects: 59
Study: 21722270

Group type: EXPERIMENTAL
Intervention: Back of the Net (BTN)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Individual Exercise (IE)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control
Number of subjects: 104
Study: 18996012

Group type: EXPERIMENTAL
Intervention: Anterior/Posterior weight shifting (WS) practice (n=20)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Medio/Lateral weight shifting (WS) practice (n=20)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (n=16)
Number of subjects: 56
Study: 16339086

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 15004731

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg b.i.d. for 6 days
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.i.d. for 6 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo for 6 days
Number of subjects: 17
Study: 10718795

Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Droperidol 20 microg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metoclopramide 0.2 mg/kg
Number of subjects: 120
Study: 9376523

Group type: EXPERIMENTAL
Intervention: Explicit conditions for surface structure learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit conditions for abstract structure learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit conditions
Number of subjects: 0
Study: 1546725

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Mealtime antacids (80 mmol/day)
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Trimipramine 25 mg
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g twice a day
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg, antacids, ranitidine 150 mg, and sucralfate
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Antacids
Number of subjects: 785
Study: 3889723

Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicergolin
Number of subjects: 0
Study: 31227385

Group type: EXPERIMENTAL
Intervention: Behavioral weight control trial
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Obesity reduction
Number of subjects: 181
Study: 30126536

Group type: EXPERIMENTAL
Intervention: Peer Network Counseling-txt (PNC-txt)
Number of subjects: 30
Study: 25809315

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 140

Group type: COMPARATOR
Intervention: Arthroscopic acromioplasty followed by a similar exercise program
Number of subjects: 140
Study: 23642733

Group type: EXPERIMENTAL
Intervention: Moderate continuous exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intense intermittent exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 30
Study: 21124256

Group type: EXPERIMENTAL
Intervention: PPV with densiron (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: PPV with silicone oil (n = 15)
Number of subjects: 30
Study: 19954711

Group type: EXPERIMENTAL
Intervention: Bemiparin 3500 IU
Number of subjects: 12

Group type: COMPARATOR
Intervention: Enoxaparin 4000 IU
Number of subjects: 12
Study: 17577112

Group type: EXPERIMENTAL
Intervention: 1000 mg hydrotalcite
Number of subjects: 562

Group type: COMPARATOR
Intervention: 10 mg famotidine
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study: 15247745

Group type: EXPERIMENTAL
Intervention: Holmium laser resection of the prostate (HoLRP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 120
Study: 12364302

Group type: EXPERIMENTAL
Intervention: Immediate DAFNE training
Number of subjects: 169

Group type: COMPARATOR
Intervention: Delayed DAFNE training
Number of subjects: 169
Study: 9691103

Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg once daily
Number of subjects: 182

Group type: COMPARATOR
Intervention: Mesalamine 2 g twice daily
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 182

Group type: COMPARATOR
Intervention: Mesalamine
Number of subjects: 182
Study: 10658944

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN)
Number of subjects: 10
Study: 1991926

Group type: EXPERIMENTAL
Intervention: ICI 204,219
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6600418

Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 100
Study: 31241784

Group type: EXPERIMENTAL
Intervention: Autogenous tooth roots (TR)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Cortical autogenous bone blocks (AB)
Number of subjects: 23
Study: 30213798

Group type: EXPERIMENTAL
Intervention: Mobile application added to usual care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 27055211

Group type: EXPERIMENTAL
Intervention: Lifitegrast ophthalmic solution 5.0%
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study: 24929350

Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 25% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 50% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 75% anivamersen reversal
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Pegnivacogin 1 mg/kg with 100% anivamersen reversal
Number of subjects: 640

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Pegnivacogin
Number of subjects: 640

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 640
Study: 23336487

Group type: EXPERIMENTAL
Intervention: Laparoscopic virtual reality simulator
Number of subjects: 26

Group type: COMPARATOR
Intervention: Laparoscopic box trainer
Number of subjects: 26
Study: 20559104

Group type: EXPERIMENTAL
Intervention: Tiopronin (3 g/d)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tiopronin (1 g/d to 3 g/d)
Number of subjects: 9
Study: 18398627

Group type: EXPERIMENTAL
Intervention: Restorative dental care (ART)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Only extractions
Number of subjects: 380

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 380

Group type: COMPARATOR
Intervention: Full dental treatment
Number of subjects: 380
Study: 15673873

Group type: EXPERIMENTAL
Intervention: Stimulation patterns (300‐500 V; 100‐1000 Hz; 1‐5 stimuli) at different propofol target plasma concentrations (PTPCs) (2, 4, and 6 microg/mL)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propofol target plasma concentrations (PTPCs) (2, 4, and 6 microg/mL)
Number of subjects: 12
Study: 12058095

Group type: EXPERIMENTAL
Intervention: Ketoprofen 75 mg
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Ketoprofen 150 mg
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 9857785

Group type: EXPERIMENTAL
Intervention: More frequent contact with family and friends among respondents with GAF scores in the lowest 20%
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Frequent social contact among better functioning respondents
Number of subjects: 331
Study: 8296845

Group type: EXPERIMENTAL
Intervention: Preterm birth prevention education plus increased clinic visits and selected prophylactic interventions
Number of subjects: 1774

Group type: COMPARATOR
Intervention: Standard county care
Number of subjects: 1774
Study: 2742247

Group type: EXPERIMENTAL
Intervention: Targeted inspiratory muscle training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (constant, nominal level of resistance)
Number of subjects: 19
Study: 1096930

Group type: EXPERIMENTAL
Intervention: 1200 calorie diet
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: cyclopenthiazide with potassium
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 51
Study: 30961672

Group type: EXPERIMENTAL
Intervention: 4 active ABCR sessions twice a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group sessions twice a week
Number of subjects: 0
Study: 28975241

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876
Study: 25694300

Group type: EXPERIMENTAL
Intervention: Insulin lispro protamine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Insulin detemir
Number of subjects: 49
Study: 23404154

Group type: EXPERIMENTAL
Intervention: Left capnothorax first (Group L)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Right capnothorax first (Group R)
Number of subjects: 40
Study: 20940648

Group type: EXPERIMENTAL
Intervention: Resistance training in water-based exercises (RWE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Water-based exercises without resistance control (WE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Non-training control (CON)
Number of subjects: 27
Study: 18847131

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment with antidepressants (specifics not provided)
Number of subjects: 0
Study: 16649858

Group type: EXPERIMENTAL
Intervention: Insecure attachment
Number of subjects: 124

Group type: COMPARATOR
Intervention: Secure attachment
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Insecurely attached partners
Number of subjects: 124

Group type: COMPARATOR
Intervention: Securely attached partners
Number of subjects: 124
Study: 12929879

Group type: COMPARATOR
Intervention: Calcium intake in children with rickets (285 +/- 113 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium intake in adolescents with rickets (305 +/- 196 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sun exposure in children with rickets (55 +/- 28 min x m2/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 25 hydroxyvitamin D in children with rickets (49 +/- 38 nmol/l)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sun exposure in adolescents with rickets (16 +/- 15 min x m2/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Serum 25 hydroxyvitamin D in adolescents with rickets (12.6 +/- 7.1 nmol/l)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Odds ratio for developing rickets with daily calcium intake below 300 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Calcium treatment (1 g daily) in children
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Calcium treatment (1 g daily) in adolescents
Number of subjects: 40
Study: 10666663

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillators (ICD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empiric amiodarone
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICD therapy
Number of subjects: 0
Study: 9272978

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1357124

Group type: EXPERIMENTAL
Intervention: sCD4 (100, 300, and 1000 micrograms/kg per day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: sCD4 plus dideoxyinosine (90 mg/m2 every 8 hours)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: sCD4 alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: sCD4 plus dideoxyinosine combination therapy
Number of subjects: 11